Rock BioMedical,Inc.

Rock BioMedical, Inc. Secures Its First U.S. IND Approval Within Three Years of Operation

Rock BioMedical Emerges as a Global Leader in Universal Vaccine Development

Low-Sugar Vaccinations – selected as One of IUPAC 2023 Top Ten Emerging Technologies in Chemistry

Rock BioMedical Secures Exclusive License to Jointly Combat Coronavirus